Anti-Malarial Drug Market

1 Study Coverage
    1.1 Anti-Malarial Drug Product Introduction
    1.2 Market by Type
        1.2.1 Global Anti-Malarial Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Plasmodium Falciparum
        1.2.3 Plasmodium Vivax
        1.2.4 Plasmodium Malariae
        1.2.5 Plasmodium Ovale
    1.3 Market by Application
        1.3.1 Global Anti-Malarial Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacy
        1.3.3 Retail Pharmacy
        1.3.4 E-Commerce
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Anti-Malarial Drug Sales Estimates and Forecasts 2017-2028
    2.2 Global Anti-Malarial Drug Revenue Estimates and Forecasts 2017-2028
    2.3 Global Anti-Malarial Drug Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Anti-Malarial Drug Sales by Region
        2.4.1 Global Anti-Malarial Drug Sales by Region (2017-2022)
        2.4.2 Global Sales Anti-Malarial Drug by Region (2023-2028)
    2.5 Global Anti-Malarial Drug Revenue by Region
        2.5.1 Global Anti-Malarial Drug Revenue by Region (2017-2022)
        2.5.2 Global Anti-Malarial Drug Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Anti-Malarial Drug Sales by Manufacturers
        3.1.1 Global Top Anti-Malarial Drug Manufacturers by Sales (2017-2022)
        3.1.2 Global Anti-Malarial Drug Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anti-Malarial Drug in 2021
    3.2 Global Anti-Malarial Drug Revenue by Manufacturers
        3.2.1 Global Anti-Malarial Drug Revenue by Manufacturers (2017-2022)
        3.2.2 Global Anti-Malarial Drug Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Anti-Malarial Drug Revenue in 2021
    3.3 Global Anti-Malarial Drug Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Anti-Malarial Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Anti-Malarial Drug Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Anti-Malarial Drug Sales by Type
        4.1.1 Global Anti-Malarial Drug Historical Sales by Type (2017-2022)
        4.1.2 Global Anti-Malarial Drug Forecasted Sales by Type (2023-2028)
        4.1.3 Global Anti-Malarial Drug Sales Market Share by Type (2017-2028)
    4.2 Global Anti-Malarial Drug Revenue by Type
        4.2.1 Global Anti-Malarial Drug Historical Revenue by Type (2017-2022)
        4.2.2 Global Anti-Malarial Drug Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Anti-Malarial Drug Revenue Market Share by Type (2017-2028)
    4.3 Global Anti-Malarial Drug Price by Type
        4.3.1 Global Anti-Malarial Drug Price by Type (2017-2022)
        4.3.2 Global Anti-Malarial Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Anti-Malarial Drug Sales by Application
        5.1.1 Global Anti-Malarial Drug Historical Sales by Application (2017-2022)
        5.1.2 Global Anti-Malarial Drug Forecasted Sales by Application (2023-2028)
        5.1.3 Global Anti-Malarial Drug Sales Market Share by Application (2017-2028)
    5.2 Global Anti-Malarial Drug Revenue by Application
        5.2.1 Global Anti-Malarial Drug Historical Revenue by Application (2017-2022)
        5.2.2 Global Anti-Malarial Drug Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Anti-Malarial Drug Revenue Market Share by Application (2017-2028)
    5.3 Global Anti-Malarial Drug Price by Application
        5.3.1 Global Anti-Malarial Drug Price by Application (2017-2022)
        5.3.2 Global Anti-Malarial Drug Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Anti-Malarial Drug Market Size by Type
        6.1.1 North America Anti-Malarial Drug Sales by Type (2017-2028)
        6.1.2 North America Anti-Malarial Drug Revenue by Type (2017-2028)
    6.2 North America Anti-Malarial Drug Market Size by Application
        6.2.1 North America Anti-Malarial Drug Sales by Application (2017-2028)
        6.2.2 North America Anti-Malarial Drug Revenue by Application (2017-2028)
    6.3 North America Anti-Malarial Drug Market Size by Country
        6.3.1 North America Anti-Malarial Drug Sales by Country (2017-2028)
        6.3.2 North America Anti-Malarial Drug Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Anti-Malarial Drug Market Size by Type
        7.1.1 Europe Anti-Malarial Drug Sales by Type (2017-2028)
        7.1.2 Europe Anti-Malarial Drug Revenue by Type (2017-2028)
    7.2 Europe Anti-Malarial Drug Market Size by Application
        7.2.1 Europe Anti-Malarial Drug Sales by Application (2017-2028)
        7.2.2 Europe Anti-Malarial Drug Revenue by Application (2017-2028)
    7.3 Europe Anti-Malarial Drug Market Size by Country
        7.3.1 Europe Anti-Malarial Drug Sales by Country (2017-2028)
        7.3.2 Europe Anti-Malarial Drug Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Anti-Malarial Drug Market Size by Type
        8.1.1 Asia Pacific Anti-Malarial Drug Sales by Type (2017-2028)
        8.1.2 Asia Pacific Anti-Malarial Drug Revenue by Type (2017-2028)
    8.2 Asia Pacific Anti-Malarial Drug Market Size by Application
        8.2.1 Asia Pacific Anti-Malarial Drug Sales by Application (2017-2028)
        8.2.2 Asia Pacific Anti-Malarial Drug Revenue by Application (2017-2028)
    8.3 Asia Pacific Anti-Malarial Drug Market Size by Region
        8.3.1 Asia Pacific Anti-Malarial Drug Sales by Region (2017-2028)
        8.3.2 Asia Pacific Anti-Malarial Drug Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Anti-Malarial Drug Market Size by Type
        9.1.1 Latin America Anti-Malarial Drug Sales by Type (2017-2028)
        9.1.2 Latin America Anti-Malarial Drug Revenue by Type (2017-2028)
    9.2 Latin America Anti-Malarial Drug Market Size by Application
        9.2.1 Latin America Anti-Malarial Drug Sales by Application (2017-2028)
        9.2.2 Latin America Anti-Malarial Drug Revenue by Application (2017-2028)
    9.3 Latin America Anti-Malarial Drug Market Size by Country
        9.3.1 Latin America Anti-Malarial Drug Sales by Country (2017-2028)
        9.3.2 Latin America Anti-Malarial Drug Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Anti-Malarial Drug Market Size by Type
        10.1.1 Middle East and Africa Anti-Malarial Drug Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Anti-Malarial Drug Revenue by Type (2017-2028)
    10.2 Middle East and Africa Anti-Malarial Drug Market Size by Application
        10.2.1 Middle East and Africa Anti-Malarial Drug Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Anti-Malarial Drug Revenue by Application (2017-2028)
    10.3 Middle East and Africa Anti-Malarial Drug Market Size by Country
        10.3.1 Middle East and Africa Anti-Malarial Drug Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Anti-Malarial Drug Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 GlaxoSmithKline
        11.1.1 GlaxoSmithKline Corporation Information
        11.1.2 GlaxoSmithKline Overview
        11.1.3 GlaxoSmithKline Anti-Malarial Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 GlaxoSmithKline Anti-Malarial Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 GlaxoSmithKline Recent Developments
    11.2 Ranbaxy
        11.2.1 Ranbaxy Corporation Information
        11.2.2 Ranbaxy Overview
        11.2.3 Ranbaxy Anti-Malarial Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Ranbaxy Anti-Malarial Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Ranbaxy Recent Developments
    11.3 Zydus Cadila
        11.3.1 Zydus Cadila Corporation Information
        11.3.2 Zydus Cadila Overview
        11.3.3 Zydus Cadila Anti-Malarial Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Zydus Cadila Anti-Malarial Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Zydus Cadila Recent Developments
    11.4 Alvizia
        11.4.1 Alvizia Corporation Information
        11.4.2 Alvizia Overview
        11.4.3 Alvizia Anti-Malarial Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Alvizia Anti-Malarial Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Alvizia Recent Developments
    11.5 Bayer
        11.5.1 Bayer Corporation Information
        11.5.2 Bayer Overview
        11.5.3 Bayer Anti-Malarial Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Bayer Anti-Malarial Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Bayer Recent Developments
    11.6 Ipca
        11.6.1 Ipca Corporation Information
        11.6.2 Ipca Overview
        11.6.3 Ipca Anti-Malarial Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Ipca Anti-Malarial Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Ipca Recent Developments
    11.7 Merck
        11.7.1 Merck Corporation Information
        11.7.2 Merck Overview
        11.7.3 Merck Anti-Malarial Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Merck Anti-Malarial Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Merck Recent Developments
    11.8 F. Hoffmann-La Roche
        11.8.1 F. Hoffmann-La Roche Corporation Information
        11.8.2 F. Hoffmann-La Roche Overview
        11.8.3 F. Hoffmann-La Roche Anti-Malarial Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 F. Hoffmann-La Roche Anti-Malarial Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 F. Hoffmann-La Roche Recent Developments
    11.9 Novartis
        11.9.1 Novartis Corporation Information
        11.9.2 Novartis Overview
        11.9.3 Novartis Anti-Malarial Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Novartis Anti-Malarial Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Novartis Recent Developments
    11.10 Pfizer
        11.10.1 Pfizer Corporation Information
        11.10.2 Pfizer Overview
        11.10.3 Pfizer Anti-Malarial Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Pfizer Anti-Malarial Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Pfizer Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Anti-Malarial Drug Industry Chain Analysis
    12.2 Anti-Malarial Drug Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Anti-Malarial Drug Production Mode & Process
    12.4 Anti-Malarial Drug Sales and Marketing
        12.4.1 Anti-Malarial Drug Sales Channels
        12.4.2 Anti-Malarial Drug Distributors
    12.5 Anti-Malarial Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Anti-Malarial Drug Industry Trends
    13.2 Anti-Malarial Drug Market Drivers
    13.3 Anti-Malarial Drug Market Challenges
    13.4 Anti-Malarial Drug Market Restraints
14 Key Findings in The Global Anti-Malarial Drug Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Anti-Malarial Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Plasmodium Falciparum
    Table 3. Major Manufacturers of Plasmodium Vivax
    Table 4. Major Manufacturers of Plasmodium Malariae
    Table 5. Major Manufacturers of Plasmodium Ovale
    Table 6. Global Anti-Malarial Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Anti-Malarial Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Anti-Malarial Drug Sales by Region (2017-2022) & (MT)
    Table 9. Global Anti-Malarial Drug Sales Market Share by Region (2017-2022)
    Table 10. Global Anti-Malarial Drug Sales by Region (2023-2028) & (MT)
    Table 11. Global Anti-Malarial Drug Sales Market Share by Region (2023-2028)
    Table 12. Global Anti-Malarial Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 13. Global Anti-Malarial Drug Revenue Market Share by Region (2017-2022)
    Table 14. Global Anti-Malarial Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 15. Global Anti-Malarial Drug Revenue Market Share by Region (2023-2028)
    Table 16. Global Anti-Malarial Drug Sales by Manufacturers (2017-2022) & (MT)
    Table 17. Global Anti-Malarial Drug Sales Share by Manufacturers (2017-2022)
    Table 18. Global Anti-Malarial Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 19. Global Anti-Malarial Drug Revenue Share by Manufacturers (2017-2022)
    Table 20. Anti-Malarial Drug Price by Manufacturers (2017-2022) &(USD/Kg)
    Table 21. Global Anti-Malarial Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Anti-Malarial Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Malarial Drug as of 2021)
    Table 23. Anti-Malarial Drug Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Anti-Malarial Drug Product Offered
    Table 25. Date of Manufacturers Enter into Anti-Malarial Drug Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Anti-Malarial Drug Sales by Type (2017-2022) & (MT)
    Table 28. Global Anti-Malarial Drug Sales by Type (2023-2028) & (MT)
    Table 29. Global Anti-Malarial Drug Sales Share by Type (2017-2022)
    Table 30. Global Anti-Malarial Drug Sales Share by Type (2023-2028)
    Table 31. Global Anti-Malarial Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 32. Global Anti-Malarial Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 33. Global Anti-Malarial Drug Revenue Share by Type (2017-2022)
    Table 34. Global Anti-Malarial Drug Revenue Share by Type (2023-2028)
    Table 35. Anti-Malarial Drug Price by Type (2017-2022) & (USD/Kg)
    Table 36. Global Anti-Malarial Drug Price Forecast by Type (2023-2028) & (USD/Kg)
    Table 37. Global Anti-Malarial Drug Sales by Application (2017-2022) & (MT)
    Table 38. Global Anti-Malarial Drug Sales by Application (2023-2028) & (MT)
    Table 39. Global Anti-Malarial Drug Sales Share by Application (2017-2022)
    Table 40. Global Anti-Malarial Drug Sales Share by Application (2023-2028)
    Table 41. Global Anti-Malarial Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 42. Global Anti-Malarial Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 43. Global Anti-Malarial Drug Revenue Share by Application (2017-2022)
    Table 44. Global Anti-Malarial Drug Revenue Share by Application (2023-2028)
    Table 45. Anti-Malarial Drug Price by Application (2017-2022) & (USD/Kg)
    Table 46. Global Anti-Malarial Drug Price Forecast by Application (2023-2028) & (USD/Kg)
    Table 47. North America Anti-Malarial Drug Sales by Type (2017-2022) & (MT)
    Table 48. North America Anti-Malarial Drug Sales by Type (2023-2028) & (MT)
    Table 49. North America Anti-Malarial Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 50. North America Anti-Malarial Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 51. North America Anti-Malarial Drug Sales by Application (2017-2022) & (MT)
    Table 52. North America Anti-Malarial Drug Sales by Application (2023-2028) & (MT)
    Table 53. North America Anti-Malarial Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 54. North America Anti-Malarial Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 55. North America Anti-Malarial Drug Sales by Country (2017-2022) & (MT)
    Table 56. North America Anti-Malarial Drug Sales by Country (2023-2028) & (MT)
    Table 57. North America Anti-Malarial Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 58. North America Anti-Malarial Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 59. Europe Anti-Malarial Drug Sales by Type (2017-2022) & (MT)
    Table 60. Europe Anti-Malarial Drug Sales by Type (2023-2028) & (MT)
    Table 61. Europe Anti-Malarial Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 62. Europe Anti-Malarial Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 63. Europe Anti-Malarial Drug Sales by Application (2017-2022) & (MT)
    Table 64. Europe Anti-Malarial Drug Sales by Application (2023-2028) & (MT)
    Table 65. Europe Anti-Malarial Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 66. Europe Anti-Malarial Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 67. Europe Anti-Malarial Drug Sales by Country (2017-2022) & (MT)
    Table 68. Europe Anti-Malarial Drug Sales by Country (2023-2028) & (MT)
    Table 69. Europe Anti-Malarial Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 70. Europe Anti-Malarial Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 71. Asia Pacific Anti-Malarial Drug Sales by Type (2017-2022) & (MT)
    Table 72. Asia Pacific Anti-Malarial Drug Sales by Type (2023-2028) & (MT)
    Table 73. Asia Pacific Anti-Malarial Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 74. Asia Pacific Anti-Malarial Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 75. Asia Pacific Anti-Malarial Drug Sales by Application (2017-2022) & (MT)
    Table 76. Asia Pacific Anti-Malarial Drug Sales by Application (2023-2028) & (MT)
    Table 77. Asia Pacific Anti-Malarial Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 78. Asia Pacific Anti-Malarial Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 79. Asia Pacific Anti-Malarial Drug Sales by Region (2017-2022) & (MT)
    Table 80. Asia Pacific Anti-Malarial Drug Sales by Region (2023-2028) & (MT)
    Table 81. Asia Pacific Anti-Malarial Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 82. Asia Pacific Anti-Malarial Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 83. Latin America Anti-Malarial Drug Sales by Type (2017-2022) & (MT)
    Table 84. Latin America Anti-Malarial Drug Sales by Type (2023-2028) & (MT)
    Table 85. Latin America Anti-Malarial Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 86. Latin America Anti-Malarial Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 87. Latin America Anti-Malarial Drug Sales by Application (2017-2022) & (MT)
    Table 88. Latin America Anti-Malarial Drug Sales by Application (2023-2028) & (MT)
    Table 89. Latin America Anti-Malarial Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 90. Latin America Anti-Malarial Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 91. Latin America Anti-Malarial Drug Sales by Country (2017-2022) & (MT)
    Table 92. Latin America Anti-Malarial Drug Sales by Country (2023-2028) & (MT)
    Table 93. Latin America Anti-Malarial Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 94. Latin America Anti-Malarial Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 95. Middle East and Africa Anti-Malarial Drug Sales by Type (2017-2022) & (MT)
    Table 96. Middle East and Africa Anti-Malarial Drug Sales by Type (2023-2028) & (MT)
    Table 97. Middle East and Africa Anti-Malarial Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 98. Middle East and Africa Anti-Malarial Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 99. Middle East and Africa Anti-Malarial Drug Sales by Application (2017-2022) & (MT)
    Table 100. Middle East and Africa Anti-Malarial Drug Sales by Application (2023-2028) & (MT)
    Table 101. Middle East and Africa Anti-Malarial Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Middle East and Africa Anti-Malarial Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa Anti-Malarial Drug Sales by Country (2017-2022) & (MT)
    Table 104. Middle East and Africa Anti-Malarial Drug Sales by Country (2023-2028) & (MT)
    Table 105. Middle East and Africa Anti-Malarial Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa Anti-Malarial Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 107. GlaxoSmithKline Corporation Information
    Table 108. GlaxoSmithKline Description and Major Businesses
    Table 109. GlaxoSmithKline Anti-Malarial Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 110. GlaxoSmithKline Anti-Malarial Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. GlaxoSmithKline Recent Developments
    Table 112. Ranbaxy Corporation Information
    Table 113. Ranbaxy Description and Major Businesses
    Table 114. Ranbaxy Anti-Malarial Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 115. Ranbaxy Anti-Malarial Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Ranbaxy Recent Developments
    Table 117. Zydus Cadila Corporation Information
    Table 118. Zydus Cadila Description and Major Businesses
    Table 119. Zydus Cadila Anti-Malarial Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 120. Zydus Cadila Anti-Malarial Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Zydus Cadila Recent Developments
    Table 122. Alvizia Corporation Information
    Table 123. Alvizia Description and Major Businesses
    Table 124. Alvizia Anti-Malarial Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 125. Alvizia Anti-Malarial Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Alvizia Recent Developments
    Table 127. Bayer Corporation Information
    Table 128. Bayer Description and Major Businesses
    Table 129. Bayer Anti-Malarial Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 130. Bayer Anti-Malarial Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Bayer Recent Developments
    Table 132. Ipca Corporation Information
    Table 133. Ipca Description and Major Businesses
    Table 134. Ipca Anti-Malarial Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 135. Ipca Anti-Malarial Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Ipca Recent Developments
    Table 137. Merck Corporation Information
    Table 138. Merck Description and Major Businesses
    Table 139. Merck Anti-Malarial Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 140. Merck Anti-Malarial Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Merck Recent Developments
    Table 142. F. Hoffmann-La Roche Corporation Information
    Table 143. F. Hoffmann-La Roche Description and Major Businesses
    Table 144. F. Hoffmann-La Roche Anti-Malarial Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 145. F. Hoffmann-La Roche Anti-Malarial Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. F. Hoffmann-La Roche Recent Developments
    Table 147. Novartis Corporation Information
    Table 148. Novartis Description and Major Businesses
    Table 149. Novartis Anti-Malarial Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 150. Novartis Anti-Malarial Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. Novartis Recent Developments
    Table 152. Pfizer Corporation Information
    Table 153. Pfizer Description and Major Businesses
    Table 154. Pfizer Anti-Malarial Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 155. Pfizer Anti-Malarial Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. Pfizer Recent Developments
    Table 157. Key Raw Materials Lists
    Table 158. Raw Materials Key Suppliers Lists
    Table 159. Anti-Malarial Drug Distributors List
    Table 160. Anti-Malarial Drug Customers List
    Table 161. Anti-Malarial Drug Market Trends
    Table 162. Anti-Malarial Drug Market Drivers
    Table 163. Anti-Malarial Drug Market Challenges
    Table 164. Anti-Malarial Drug Market Restraints
    Table 165. Research Programs/Design for This Report
    Table 166. Key Data Information from Secondary Sources
    Table 167. Key Data Information from Primary Sources
List of Figures
    Figure 1. Anti-Malarial Drug Product Picture
    Figure 3. Global Anti-Malarial Drug Market Share by Type in 2021 & 2028
    Figure 3. Plasmodium Falciparum Product Picture
    Figure 4. Plasmodium Vivax Product Picture
    Figure 5. Plasmodium Malariae Product Picture
    Figure 6. Plasmodium Ovale Product Picture
    Figure 7. Global Anti-Malarial Drug Market Share by Application in 2021 & 2028
    Figure 8. Hospital Pharmacy
    Figure 9. Retail Pharmacy
    Figure 10. E-Commerce
    Figure 11. Others
    Figure 12. Anti-Malarial Drug Report Years Considered
    Figure 13. Global Anti-Malarial Drug Sales 2017-2028 (MT)
    Figure 14. Global Anti-Malarial Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Anti-Malarial Drug Revenue 2017-2028 (US$ Million)
    Figure 16. Global Anti-Malarial Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 17. Global Anti-Malarial Drug Sales Market Share by Region (2017-2022)
    Figure 18. Global Anti-Malarial Drug Sales Market Share by Region (2023-2028)
    Figure 19. North America Anti-Malarial Drug Sales YoY (2017-2028) & (MT)
    Figure 20. North America Anti-Malarial Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Europe Anti-Malarial Drug Sales YoY (2017-2028) & (MT)
    Figure 22. Europe Anti-Malarial Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Asia-Pacific Anti-Malarial Drug Sales YoY (2017-2028) & (MT)
    Figure 24. Asia-Pacific Anti-Malarial Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Latin America Anti-Malarial Drug Sales YoY (2017-2028) & (MT)
    Figure 26. Latin America Anti-Malarial Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Middle East & Africa Anti-Malarial Drug Sales YoY (2017-2028) & (MT)
    Figure 28. Middle East & Africa Anti-Malarial Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. The Anti-Malarial Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 30. The Top 5 and 10 Largest Manufacturers of Anti-Malarial Drug in the World: Market Share by Anti-Malarial Drug Revenue in 2021
    Figure 31. Global Anti-Malarial Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 32. Global Anti-Malarial Drug Sales Market Share by Type (2017-2028)
    Figure 33. Global Anti-Malarial Drug Revenue Market Share by Type (2017-2028)
    Figure 34. Global Anti-Malarial Drug Sales Market Share by Application (2017-2028)
    Figure 35. Global Anti-Malarial Drug Revenue Market Share by Application (2017-2028)
    Figure 36. North America Anti-Malarial Drug Sales Market Share by Type (2017-2028)
    Figure 37. North America Anti-Malarial Drug Revenue Market Share by Type (2017-2028)
    Figure 38. North America Anti-Malarial Drug Sales Market Share by Application (2017-2028)
    Figure 39. North America Anti-Malarial Drug Revenue Market Share by Application (2017-2028)
    Figure 40. North America Anti-Malarial Drug Sales Share by Country (2017-2028)
    Figure 41. North America Anti-Malarial Drug Revenue Share by Country (2017-2028)
    Figure 42. U.S. Anti-Malarial Drug Revenue (2017-2028) & (US$ Million)
    Figure 43. Canada Anti-Malarial Drug Revenue (2017-2028) & (US$ Million)
    Figure 44. Europe Anti-Malarial Drug Sales Market Share by Type (2017-2028)
    Figure 45. Europe Anti-Malarial Drug Revenue Market Share by Type (2017-2028)
    Figure 46. Europe Anti-Malarial Drug Sales Market Share by Application (2017-2028)
    Figure 47. Europe Anti-Malarial Drug Revenue Market Share by Application (2017-2028)
    Figure 48. Europe Anti-Malarial Drug Sales Share by Country (2017-2028)
    Figure 49. Europe Anti-Malarial Drug Revenue Share by Country (2017-2028)
    Figure 50. Germany Anti-Malarial Drug Revenue (2017-2028) & (US$ Million)
    Figure 51. France Anti-Malarial Drug Revenue (2017-2028) & (US$ Million)
    Figure 52. U.K. Anti-Malarial Drug Revenue (2017-2028) & (US$ Million)
    Figure 53. Italy Anti-Malarial Drug Revenue (2017-2028) & (US$ Million)
    Figure 54. Russia Anti-Malarial Drug Revenue (2017-2028) & (US$ Million)
    Figure 55. Asia Pacific Anti-Malarial Drug Sales Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Anti-Malarial Drug Revenue Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Anti-Malarial Drug Sales Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Anti-Malarial Drug Revenue Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Anti-Malarial Drug Sales Share by Region (2017-2028)
    Figure 60. Asia Pacific Anti-Malarial Drug Revenue Share by Region (2017-2028)
    Figure 61. China Anti-Malarial Drug Revenue (2017-2028) & (US$ Million)
    Figure 62. Japan Anti-Malarial Drug Revenue (2017-2028) & (US$ Million)
    Figure 63. South Korea Anti-Malarial Drug Revenue (2017-2028) & (US$ Million)
    Figure 64. India Anti-Malarial Drug Revenue (2017-2028) & (US$ Million)
    Figure 65. Australia Anti-Malarial Drug Revenue (2017-2028) & (US$ Million)
    Figure 66. Taiwan Anti-Malarial Drug Revenue (2017-2028) & (US$ Million)
    Figure 67. Indonesia Anti-Malarial Drug Revenue (2017-2028) & (US$ Million)
    Figure 68. Thailand Anti-Malarial Drug Revenue (2017-2028) & (US$ Million)
    Figure 69. Malaysia Anti-Malarial Drug Revenue (2017-2028) & (US$ Million)
    Figure 70. Philippines Anti-Malarial Drug Revenue (2017-2028) & (US$ Million)
    Figure 71. Latin America Anti-Malarial Drug Sales Market Share by Type (2017-2028)
    Figure 72. Latin America Anti-Malarial Drug Revenue Market Share by Type (2017-2028)
    Figure 73. Latin America Anti-Malarial Drug Sales Market Share by Application (2017-2028)
    Figure 74. Latin America Anti-Malarial Drug Revenue Market Share by Application (2017-2028)
    Figure 75. Latin America Anti-Malarial Drug Sales Share by Country (2017-2028)
    Figure 76. Latin America Anti-Malarial Drug Revenue Share by Country (2017-2028)
    Figure 77. Mexico Anti-Malarial Drug Revenue (2017-2028) & (US$ Million)
    Figure 78. Brazil Anti-Malarial Drug Revenue (2017-2028) & (US$ Million)
    Figure 79. Argentina Anti-Malarial Drug Revenue (2017-2028) & (US$ Million)
    Figure 80. Middle East and Africa Anti-Malarial Drug Sales Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Anti-Malarial Drug Revenue Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Anti-Malarial Drug Sales Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Anti-Malarial Drug Revenue Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Anti-Malarial Drug Sales Share by Country (2017-2028)
    Figure 85. Middle East and Africa Anti-Malarial Drug Revenue Share by Country (2017-2028)
    Figure 86. Turkey Anti-Malarial Drug Revenue (2017-2028) & (US$ Million)
    Figure 87. Saudi Arabia Anti-Malarial Drug Revenue (2017-2028) & (US$ Million)
    Figure 88. U.A.E Anti-Malarial Drug Revenue (2017-2028) & (US$ Million)
    Figure 89. Anti-Malarial Drug Value Chain
    Figure 90. Anti-Malarial Drug Production Process
    Figure 91. Channels of Distribution
    Figure 92. Distributors Profiles
    Figure 93. Bottom-up and Top-down Approaches for This Report
    Figure 94. Data Triangulation
    Figure 95. Key Executives Interviewed